Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating enriched case data from national laboratory testing with population-based case-control analyses: a novel statistical likelihood-ratio methodology for PS4 applied to 325,345 breast cancer cases and 671,006 controls.

medRxiv : the preprint server for health sciences·2026
Same author

Multiplatform curation in the development of ACMG/AMP specifications for Von Hippel-Lindau (VHL) disease.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification.

Nature communications·2026
Same author

Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants.

American journal of human genetics·2026
Same author

Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.

American journal of human genetics·2026
Same author

Molecular Characterization of Vascular Anomalies Tissues Guides Clinical Diagnosis.

Lymphatic research and biology·2026

Related Experiment Video

Updated: Apr 7, 2026

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
09:40

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9

Published on: January 3, 2015

96.9K

Processed Pseudogene Confounding Deletion/Duplication Assays for SMAD4.

Alison Millson1, Tracey Lewis1, Tina Pesaran2

  • 1ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah.

The Journal of Molecular Diagnostics : JMD
|July 14, 2015
PubMed
Summary
This summary is machine-generated.

This study identifies the first processed SMAD4 pseudogene, impacting genetic testing accuracy. Awareness of this pseudogene is crucial for reliable SMAD4 variant interpretation and diagnostic assay design.

More Related Videos

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

12.4K
Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells
11:31

Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells

Published on: April 2, 2016

14.9K

Related Experiment Videos

Last Updated: Apr 7, 2026

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
09:40

Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9

Published on: January 3, 2015

96.9K
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
10:41

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

12.4K
Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells
11:31

Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells

Published on: April 2, 2016

14.9K

Area of Science:

  • Genetics
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Mutations in SMAD4 are linked to juvenile polyposis syndrome and related disorders.
  • The SMAD gene family includes SMAD4, but a SMAD4 pseudogene has not been previously reported.

Purpose of the Study:

  • To report the discovery of a processed SMAD4 pseudogene.
  • To highlight the implications of this pseudogene for genetic testing and diagnostic accuracy.

Main Methods:

  • Utilized multiplex ligation-dependent probe amplification and chromosomal microarray for initial detection.
  • Employed real-time quantitative PCR and exon/exon junction sequencing for confirmation.
  • Analyzed clinical data from two laboratories to determine pseudogene frequency.

Main Results:

  • Confirmed the existence of a processed SMAD4 pseudogene.
  • Found a frequency of 0.26% (12/4672 cases) for the SMAD4 processed pseudogene.
  • Demonstrated that the pseudogene can lead to false-positive/false-negative results in quantitative assays and erroneous variant calls in next-generation sequencing.

Conclusions:

  • This is the first report of a processed SMAD4 pseudogene.
  • Knowledge of this pseudogene is essential for accurate interpretation of clinical diagnostic tests.
  • Recommends Sanger sequencing for SMAD4 variant confirmation to avoid pseudogene-related errors.